[Neurologic complications following medical treatment of epileptic patients].
Neurological complications due to anticonvulsive treatment was analyzed in 48 epileptic patients. It is demonstrated that there is a changed structure and increased frequency of epileptic paroxysms in appearance of neurological complications. Special attention is drawn to the significance of residual signs in organic diseases and to their occurrence. Recommendations are given for prevention and treatment of complications.
D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D001259:Ataxia / Q000139:chemically induced; D001569:Benzodiazepines / Q000009:adverse effects; D003244:Consciousness Disorders / Q000139:chemically induced; D004401:Dysarthria / Q000139:chemically induced; D005133:Eye Movements; D005260:Female; D006236:Handwriting; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008297:Male; D009069:Movement Disorders / Q000139:chemically induced*; D009422:Nervous System Diseases / Q000139:chemically induced*; D009759:Nystagmus, Pathologic / Q000139:chemically induced; D010523:Peripheral Nervous System Diseases / Q000139:chemically induced; D010634:Phenobarbital / Q000009:adverse effects; D010672:Phenytoin / Q000009:adverse effects; D012893:Sleep Wake Disorders / Q000139:chemically induced; D014202:Tremor / Q000139:chemically induced
D000927:Anticonvulsants; D001569:Benzodiazepines; D010672:Phenytoin; D010634:Phenobarbital
Nevrologicheskie oslozhneniia pri medikamentoznom lechenii bol'nykh épilepsieĭ.